127 related articles for article (PubMed ID: 35482266)
1. ASO Author Reflections: The PlasmaJet
Nieuwenhuyzen-de Boer GM; van Beekhuizen HJ
Ann Surg Oncol; 2022 Aug; 29(8):4844-4845. PubMed ID: 35482266
[No Abstract] [Full Text] [Related]
2. Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review.
Nieuwenhuyzen-de Boer GM; van der Kooy J; van Beekhuizen HJ
J Ovarian Res; 2019 Jul; 12(1):71. PubMed ID: 31362769
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands.
Nieuwenhuyzen-de Boer GM; Hofhuis W; Reesink-Peters N; Ewing-Graham PC; Schoots IG; Beltman JJ; Piek JMJ; Baalbergen A; Kooi GS; van Haaften A; van Huisseling H; Haans L; Dorman M; van Beekhuizen HJ
BMC Cancer; 2019 Jan; 19(1):58. PubMed ID: 30642296
[TBL] [Abstract][Full Text] [Related]
4. ASO Author Reflections: Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer.
Marchetti C; Fagotti A; Scambia G; De Felice F
Ann Surg Oncol; 2021 Jun; 28(6):3264-3265. PubMed ID: 33123859
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Total Parietal Peritonectomy During Interval Cytoreductive Surgery for Advanced Ovarian Cancer-Proof-of-Principle and Analysis of Morbidity.
Bhatt A; Kammar P; Mehta S; Sinukumar S
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):861-862. PubMed ID: 32720047
[No Abstract] [Full Text] [Related]
6. Cost Study of the PlasmaJet Surgical Device Versus Conventional Cytoreductive Surgery in Patients With Advanced-Stage Ovarian Cancer.
Nieuwenhuyzen-de Boer GM; Geraerds AJLM; van der Linden MH; van Doorn HC; Polinder S; van Beekhuizen HJ
JCO Clin Cancer Inform; 2022 Sep; 6():e2200076. PubMed ID: 36198130
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands.
Nieuwenhuyzen-de Boer GM; Hofhuis W; Reesink-Peters N; Willemsen S; Boere IA; Schoots IG; Piek JMJ; Hofman LN; Beltman JJ; van Driel WJ; Werner HMJ; Baalbergen A; van Haaften-de Jong AMLD; Dorman M; Haans L; Nedelcu I; Ewing-Graham PC; van Beekhuizen HJ
Ann Surg Oncol; 2022 Aug; 29(8):4833-4843. PubMed ID: 35552938
[TBL] [Abstract][Full Text] [Related]
8. ASO Author Reflections: Rectosigmoid Mesorectal Sparing Resection: A Feasible Technique and a Viable Option in Advanced Ovarian Cancer Surgery.
Rosati A; Vargiu V; Santullo F; Lodoli C; Attalla El Halabieh M; Scambia G; Fagotti A; Costantini B
Ann Surg Oncol; 2021 Oct; 28(11):6723-6724. PubMed ID: 33575871
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Personalized Surgery in Recurrent Ovarian Cancer Patients.
Estati FL; Baiocchi G; da Costa AABA
Ann Surg Oncol; 2021 Jul; 28(7):3646-3647. PubMed ID: 33211231
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Redefining Consolidation Cytoreductive Surgery for Ovarian Cancer.
Bhatt A; Alcazer V; Frankinet L; Bakrin N; Glehen O
Ann Surg Oncol; 2023 Jun; 30(6):3300-3301. PubMed ID: 36808321
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Value of Cytoreduction in Extensive Ovarian Cancer-Does Surgical Effort Still Matter?
Fotopoulou C
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):786-787. PubMed ID: 31605337
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery-What We Know and Future Perspectives.
Vargiu V; Santullo F; Rosati A; Costantini B; Gallotta V; Lodoli C; Pacelli F; Scambia G; Fagotti A
Ann Surg Oncol; 2022 Aug; 29(8):4803-4804. PubMed ID: 35430663
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer.
Petrillo M; Scambia G; Fagotti A
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):886-887. PubMed ID: 30414040
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Minimally Invasive Secondary Cytoreductive Surgery for Ovarian Cancer Lymph Node Recurrence: Shaping Treatment with All Arrows in our Quiver.
Loverro M; Ergasti R; Conte C; Gallitelli V; Nachira D; Scaglione G; Fagotti A; Scambia G; Gallotta V
Ann Surg Oncol; 2022 Apr; 29(4):2605-2606. PubMed ID: 35066718
[No Abstract] [Full Text] [Related]
15. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
[TBL] [Abstract][Full Text] [Related]
16. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet® device.
Natarajan P; Martha Schofield A; Elena Vinturache A; Ruthven S; Lane S; Duncan Macdonald R
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():311-315. PubMed ID: 38518485
[TBL] [Abstract][Full Text] [Related]
18. Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer.
Panuccio E; Leunen K; Van Nieuwenhuysen E; Neven P; Lambrechts S; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1521-4. PubMed ID: 27488213
[TBL] [Abstract][Full Text] [Related]
19. A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer.
Chesnais M; Lecuru F; Mimouni M; Ngo C; Fauconnier A; Huchon C
PLoS One; 2017; 12(11):e0187245. PubMed ID: 29117194
[TBL] [Abstract][Full Text] [Related]
20. ASO Author Reflections: HIPEC with Cisplatin Improves Prognosis in Advanced Ovarian Cancer after Neoadjuvant Chemotherapy.
Cascales Campos PA; González Gil A
Ann Surg Oncol; 2022 Apr; 29(4):2626-2627. PubMed ID: 34977982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
